X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7868) 7868
Publication (537) 537
Book Review (71) 71
Magazine Article (11) 11
Book Chapter (9) 9
Conference Proceeding (5) 5
Paper (4) 4
Data Set (3) 3
Reference (3) 3
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5936) 5936
atorvastatin (5189) 5189
male (4283) 4283
index medicus (4202) 4202
female (3589) 3589
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (3392) 3392
middle aged (3123) 3123
statins (3094) 3094
atorvastatin calcium (2917) 2917
pyrroles - therapeutic use (2641) 2641
heptanoic acids - therapeutic use (2638) 2638
aged (2355) 2355
cholesterol (1837) 1837
pharmacology & pharmacy (1754) 1754
simvastatin (1730) 1730
treatment outcome (1658) 1658
cardiac & cardiovascular systems (1650) 1650
adult (1530) 1530
anticholesteremic agents - therapeutic use (1471) 1471
animals (1367) 1367
cholesterol, ldl - blood (1259) 1259
risk factors (1243) 1243
pravastatin (1117) 1117
atherosclerosis (1025) 1025
prevention (969) 969
risk (968) 968
hypercholesterolemia - drug therapy (925) 925
therapy (890) 890
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (863) 863
lipids (862) 862
pyrroles - pharmacology (843) 843
heptanoic acids - pharmacology (839) 839
coronary-heart-disease (833) 833
peripheral vascular disease (795) 795
hypercholesterolemia (788) 788
analysis (786) 786
medicine, general & internal (766) 766
simvastatin - therapeutic use (753) 753
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (750) 750
rosuvastatin (750) 750
antilipemic agents (731) 731
statin (708) 708
care and treatment (703) 703
inflammation (703) 703
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (698) 698
disease (690) 690
drug therapy (687) 687
drug therapy, combination (680) 680
cardiovascular disease (668) 668
pyrroles - administration & dosage (657) 657
heptanoic acids - administration & dosage (656) 656
double-blind method (632) 632
rats (632) 632
mortality (627) 627
prospective studies (625) 625
research (617) 617
c-reactive protein (614) 614
cardiovascular (613) 613
time factors (612) 612
cardiovascular-disease (607) 607
cholesterol - blood (605) 605
dose-response relationship, drug (591) 591
myocardial-infarction (585) 585
efficacy (580) 580
cardiovascular diseases (563) 563
abridged index medicus (524) 524
cardiovascular diseases - prevention & control (524) 524
safety (518) 518
cardiovascular agents (517) 517
low density lipoproteins (513) 513
lipids - blood (506) 506
triglycerides - blood (506) 506
coronary heart disease (497) 497
aged, 80 and over (496) 496
events (488) 488
statin therapy (485) 485
cholesterol, hdl - blood (482) 482
diabetes (479) 479
rosuvastatin calcium (478) 478
hypolipidemic agents - therapeutic use (475) 475
follow-up studies (468) 468
randomized controlled trials as topic (466) 466
hyperlipidemias - drug therapy (461) 461
mice (442) 442
medicine & public health (440) 440
metaanalysis (435) 435
retrospective studies (434) 434
health aspects (424) 424
dyslipidemias - drug therapy (415) 415
cardiology (412) 412
dosage and administration (408) 408
biomarkers - blood (405) 405
oxidative stress (404) 404
hypercholesterolemia - blood (402) 402
pyrroles - adverse effects (399) 399
heptanoic acids - adverse effects (398) 398
expression (396) 396
ezetimibe (395) 395
pravastatin - therapeutic use (388) 388
medicine, research & experimental (385) 385
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7563) 7563
German (65) 65
Spanish (62) 62
Russian (55) 55
Chinese (52) 52
French (32) 32
Japanese (17) 17
Italian (10) 10
Polish (7) 7
Hungarian (6) 6
Ukrainian (6) 6
Turkish (4) 4
Dutch (3) 3
Portuguese (3) 3
Czech (2) 2
Danish (1) 1
Korean (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Heart Journal, ISSN 0002-8703, 2014, Volume 168, Issue 5, pp. 682 - 689.e1
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 22, pp. 2078 - 2087
In this trial, intravascular ultrasonography was used to compare the effects of atorvastatin versus rosuvastatin on regression of coronary atherosclerosis.... 
MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | CARDIOVASCULAR EVENTS | ATHEROSCLEROSIS | INTRAVASCULAR ULTRASOUND | RANDOMIZED CONTROLLED-TRIAL | AVERAGE CHOLESTEROL LEVELS | ROSUVASTATIN | ARTERY-DISEASE | ATORVASTATIN | Coronary Vessels - diagnostic imaging | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Ultrasonography, Interventional | Male | Heptanoic Acids - adverse effects | Coronary Artery Disease - pathology | Pyrroles - adverse effects | Cholesterol, LDL - blood | Female | Pyrroles - therapeutic use | Coronary Vessels - pathology | Double-Blind Method | Rosuvastatin Calcium | Coronary Artery Disease - drug therapy | Anticholesteremic Agents - adverse effects | Disease Progression | Atorvastatin Calcium | Coronary Artery Disease - diagnostic imaging | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Sulfonamides - therapeutic use | Pyrimidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Pyrimidines - adverse effects | Cholesterol, HDL - blood | Sulfonamides - adverse effects | Aged | Fluorobenzenes - adverse effects | Fluorobenzenes - therapeutic use | Drugs | Rosuvastatin | Dosage and administration | Product/Service Evaluations | Drug therapy | Atherosclerosis | Lipoproteins (low density) | Clinical trials | Cardiovascular disease | Patients | Cholesterol | Studies | Side effects | Ultrasonic imaging | Arteriosclerosis | Ultrasonography | Atorvastatin | Heart diseases | Lipoproteins (high density) | Statins
Journal Article
Current Medical Research & Opinion, ISSN 0300-7995, 01/2013, Volume 29, Issue 1, pp. 1 - 12
Abstract Background: Rifampin is a potent inducer of both cytochrome P-450 oxidative enzymes and the P-glycoprotein transport system. Among numerous well... 
Rifabutin | Rifampin | Rifapentine | Drug interactions | MEDICINE, RESEARCH & EXPERIMENTAL | ENZYME-INDUCTION | PLATELET-AGGREGATION | TUBERCULOSIS | OPEN-LABEL | ATORVASTATIN | SINGLE-BLIND | MEDICINE, GENERAL & INTERNAL | PHARMACOKINETICS | PLASMA-CONCENTRATIONS | HEALTHY-VOLUNTEERS | TRANSPORTER INHIBITION | Rifampin - analogs & derivatives | Simvastatin - therapeutic use | Antifungal Agents - adverse effects | Digoxin - adverse effects | Simvastatin - adverse effects | Antibiotics, Antitubercular - adverse effects | Humans | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Antifungal Agents - therapeutic use | Rifampin - adverse effects | Verapamil - therapeutic use | Drug Interactions | Verapamil - adverse effects | Rifampin - therapeutic use | Contraceptives, Oral - adverse effects | Contraceptives, Oral - therapeutic use | Digoxin - therapeutic use | HIV Protease Inhibitors - adverse effects | Rifabutin - adverse effects | Anti-Arrhythmia Agents - therapeutic use | HIV Protease Inhibitors - therapeutic use | Anticholesteremic Agents - adverse effects | Itraconazole - therapeutic use | Anticholesteremic Agents - therapeutic use | Anti-Arrhythmia Agents - adverse effects | Itraconazole - adverse effects | Antibiotics, Antitubercular - therapeutic use | Cytochrome P-450 Enzyme System - biosynthesis | Rifabutin - therapeutic use | ATP Binding Cassette Transporter, Sub-Family B | Index Medicus
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 19, pp. 1809 - 1819
Journal Article
Circulation, ISSN 0009-7322, 08/2004, Volume 110, Issue 9, pp. 1061 - 1068
Journal Article
International Journal of Cancer, ISSN 0020-7136, 09/2008, Volume 123, Issue 5, pp. 983 - 990
Statins and nonsteroidal antiinflammatory drugs (NSAIDs) are commonly prescribed for lowering cholesterol and antiinflammation, respectively. Recently, their... 
cancer chemoprevention | statins | NSAIDs | Cancer chemoprevention | Statins | CELECOXIB INDUCES APOPTOSIS | HUMAN LUNG-CANCER | SELECTIVE COX-2 INHIBITORS | PREVENT COLORECTAL ADENOMAS | COLON-CANCER | ONCOLOGY | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | CHOLESTEROL-LOWERING DRUGS | FAMILIAL ADENOMATOUS POLYPOSIS | NF-KAPPA-B | ENDOTHELIAL GROWTH-FACTOR | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Simvastatin - therapeutic use | Meta-Analysis as Topic | Pyrazoles - therapeutic use | Heptanoic Acids - therapeutic use | Humans | Neoplasms - prevention & control | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Fatty Acids, Monounsaturated - therapeutic use | Anticarcinogenic Agents - administration & dosage | Aspirin - therapeutic use | Drug Therapy, Combination | Pyrroles - therapeutic use | Anticarcinogenic Agents - pharmacology | Pravastatin - therapeutic use | Anticarcinogenic Agents - therapeutic use | Pyridines - therapeutic use | Lovastatin - therapeutic use | Drug Administration Schedule | Colorectal Neoplasms - prevention & control | Celecoxib | Sulindac - therapeutic use | Evidence-Based Medicine | Randomized Controlled Trials as Topic | Drug Synergism | Atorvastatin Calcium | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Sulfonamides - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Indoles - therapeutic use | Index Medicus
Journal Article